AH Equity Partners Bio IV, L.L.C. — SEC Form 4 filings

SEC reporting owner CIK 1889898. 2 Form 4 filings on record with FilingPulse; latest filed 2026-08-11.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2024-10-17 to 2026-08-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Braveheart Bio, Inc. (BRVE)10% owner11 leg · 1,100,000 sh · $19,800,0002
Camp4 Therapeutics Corp (CAMP)10% owner12 legs · 727,272 sh · $7,999,9923

Form 4 filings — AH Equity Partners Bio IV, L.L.C.

FiledFormIssuerReported transactionsSource
2026-08-114Braveheart Bio, Inc. (BRVE)
jointly with AH Bio Fund IV, L.P., Andreessen Marc L, HOROWITZ BENJAMIN A
Conversion (C): 9,132,420 · Purchase (P): 1,100,000 @ $18 · Conversion (C): 40,000,000 (derivative) @ $0EDGAR
2024-10-174Camp4 Therapeutics Corp (CAMP)
jointly with AH Equity Partners Bio I, L.L.C., AH Bio Fund I, L.P., AH Bio Fund IV, L.P., Andreessen Marc L, HOROWITZ BENJAMIN A
Conversion (C): 1,398,067 · Purchase (P): 181,818 @ $11 · Purchase (P): 545,454 @ $11 · Conversion (C): 15,001,312 (derivative) · Conversion (C): 679,163 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1889898 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →